http://orcid.org/0000-0002-7548-0315
References
- Alhalaweh A, George S, Basavoju S, Childs SL, Rizvi SAA, Velaga SP. 2012. Pharmaceutical cocrystals of nitrofurantoin: screening, characterization and crystal structure analysis. Cryst Eng Comm. 14(15):5078–5088.
- Chen Y, Liu C, Chen Z, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F. 2015. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions. Mol Pharm. 12(2):576–589.
- Cherukuvada S, Babu NJ, Nangia A. 2011. Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies. J Pharm Sci. 100(8):3233–3244.
- Dalsania S, Sharma J, Munjal B, Bansal AK. 2018. Impact of drug-polymer miscibility on enthalpy relaxation of irbesartan amorphous solid dispersions. Pharm Res. 35(2):29.
- Gadade DD, Pekamwar SS. 2016. Pharmaceutical cocrystals: regulatory and strategic aspects, design and development. Adv Pharm Bull. 6(4):479–494.
- Ghanavati R, Taheri A, Homayouni A. 2017. Anomalous dissolution behavior of celecoxib in PVP/isomalt solid dispersions prepared using spray drier. Mater Sci Eng C Mater Biol Appl. 72:501–511.
- He Y, Ho C. 2015. Amorphous solid dispersions: utilization and challenges in drug discovery and development. J Pharm Sci. 104(10):3237–3258.
- Karagianni A, Malamatari M, Kachrimanis K. 2018. Pharmaceutical cocrystals: new solid phase modification approaches for the formulation of APIs. Pharmaceutics. 10(1):18.
- Karashima M, Sano N, Yamamoto S, Arai Y, Yamamoto K, Amano N, Ikeda Y. 2017. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations. Eur J Pharm Biopharm. 115:65–72.
- Karimi-Jafari M, Padrela L, Walker GM, Croker DM. 2018. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Crystal Growth Design. 18(10):6370–6387.
- Leonardi D, Salomon CJ. 2013. Unexpected performance of physical mixtures over solid dispersions on the dissolution behavior of benznidazole from tablets. J Pharm Sci. 102(3):1016–1023.
- Lim RTY, Ong CK, Cheng S, Ng WK. 2017. Amorphization of crystalline active pharmaceutical ingredients via formulation technologies. Powder Technol. 311:175–184.
- Maincent J, Williams RO. 3rd. 2018. Sustained-release amorphous solid dispersions. Drug Deliv Transl Res. 8(6):1714–1725.
- Newman A, Zografi G. 2019. An examination of water vapor sorption by multicomponent crystalline and amorphous solids and its effects on their solid-state properties. J Pharm Sci. 108(3):1061–1080.
- Novelli A, Rosi E. 2017. Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections. J Chemother. 29(sup1):10–18.
- Qiao N, Li M, Schlindwein W, Malek N, Davies A, Trappitt G. 2011. Pharmaceutical cocrystals: an overview. Int J Pharm. 419(1-2):1–11.
- Raijada D, Arnfast L, Bond A, Aho J, Bøtker J, Sandler N, Rantanen J. 2017. Dehydration of nitrofurantoin monohydrate during melt extrusion. Crystal Growth Design. 17(7):3707–3715.
- Ristroph KD, Feng J, McManus SA, Zhang Y, Gong K, Ramachandruni H, White CE, Prud’homme RK. 2019. Spray drying OZ439 nanoparticles to form stable, water-dispersible powders for oral malaria therapy. J Transl Med. 17(1):97.
- Stavropoulos K, Johnston SC, Zhang Y, Rao BG, Hurrey M, Hurter P, Topp EM, Kadiyala I. 2015. Cocrystalline solids of telaprevir with enhanced oral absorption. J Pharm Sci. 104(10):3343–3350.
- Sun Y, Zhu L, Wu T, Cai T, Gunn EM, Yu L. 2012. Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additives. Aaps J. 14(3):380–388.
- Tian F, Baldursdottir S, Rantanen J. 2009. Effects of polymer additives on the crystallization of hydrates: a molecular-level modulation. Mol Pharm. 6(1):202–210.
- Verma M, Nanda A, Kumar Y. 2019. Self-emulsifying drug delivery system of simvastatin: formulation development, optimization by Box-Behnken design, in-vitro and in-situ Single-Pass Intestinal Perfusion (SPIP) studies. Recent Pat Drug Deliv Formul. 12(3):199–211.
- Yonashiro H, Higashi K, Morikawa C, Ueda K, Itoh T, Ito M, Masu H, Noguchi S, Moribe K. 2018. Morphological and physicochemical evaluation of two distinct glibenclamide/hypromellose amorphous nanoparticles prepared by the antisolvent method. Mol Pharm. 15(4):1587–1597.
- Zhang Z, Cai Q, Xue J, Qin J, Liu J, Du Y. 2019. Co-crystal formation of antibiotic nitrofurantoin drug and melamine co-former based on a vibrational spectroscopic study. Pharmaceutics. 11(2):56.